Results 31 to 40 of about 9,105 (204)

Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women [PDF]

, 2013
BACKGROUND: There is no consensus on the standard treatment options for female pattern androgenetic alopecia (AGA). Efficacy of finasteride in women is controversial. The purpose of this study was to evaluate the clinical efficacy and safety of 5 mg/day
André, MC, Correia, MP, Maia e Silva, J, Oliveira-Soares, R   +3 more
core   +1 more source

Introduction to skin aging [PDF]

, 2016
YesCutaneous science has seen considerable development in the last 25 years, in part due to the -Omics revolution, and the appreciation that this organ is hardwired into the body’s key neuroimmuno- endocrine axes.
Affinito, Ashcroft, Batisse, Baumann, Ben-Yehuda, Bernstein, Bernstein, Bhushan, Bolognia, Bosset, Bosset, Branchet, Braverman, Brincat, Brincat, Brincat, Brincat, Calleja-Agius, Callens, Cerimele, Choi, Christensen, Christophers, Chuong, Commo, Contet-Audonneau, Dunn, Ellis, Ernster, Escoffier, Farage, Farage, Fenske, Garn, Ghadially, Gilchrest, Gilchrest, Gilchrest, Gniadecka, Gniadecka, Gniadecka, Gniadecka, Goodson, Graham-Brown, Grove, Grove, Grove, Gunn, Hachem, Hall, Harvell, Hay, Helmdach, Hurley, Kadono, Kadunce, Karnik, Kauser, Keogh, Kligman, Kligman, Kochevar, Kosmadaki, Landau, Lavker, Lavker, Leyden, Li, Lovell, Makinodan, Makrantonaki, Montagna, Nakamura, Nishimura, Nordlund, Oberste-Lehn, Oikarinen, Olsen, Orentreich, Panhard, Parsons, Plewig, Plowden, Pochi, Rees, Richard, Rittié, Ritz-Timme, Robert, Robinson, Saint Leger, Sandby-Moller, Sator, Scharffetter-Kochanek, Schreml, Seite, Seité, Shetage, Shuster, Silver, Smith, Thiers, Thornton, Tobin, Tobin, Tobin, Toyoda, Tsuji, Tur, Uitto, Unver, Varani, Waldorf, Waller, Watson, Watson, Watson, Whiting, Winkelmann, Yaar, Yin, Yin, Young   +122 more
core   +1 more source

Polycystic ovary syndrome: a dermatologic approach [PDF]

, 2011
Polycystic ovary syndrome (POS) is one of the most common endocrine abnormalities affecting women of reproductive age. It is a cause of significant social embarrassment and emotional distress.
Bagatin, Edileia, Costa, Dailana Louvain Marinho, Manela-azulay, Mônica, Moura, Heloisa Helena Gonçalves De, Sodré, Celso Tavares   +4 more
core   +3 more sources

Treatment of lipomas and diffuse lipomatosis with NDYAG 1064 NM laser and their impact on the quality of life [PDF]

, 2020
Lipomas, the most common type of benign tumours, are generally developed from adipose tissue and present an incidence of 2.1 per 1000 inhabitants. In addition to lipomas, at least three other maladies of the adipose tissue lead patients to consult a ...
Andronache, Liliana Florina, Ardeleanu, Valeriu, Balalau, Cristian, Gherghiceanu, Florentina, Pantea Stoian, Anca, Paunica, Stana   +5 more
core   +3 more sources

Association of Male Androgenetic Alopecia with Psychosocial and Sexual Well-being in Early Middle-aged Men: A Northern Finland Birth Cohort 1986 Study

Acta Dermato-Venereologica
Androgenetic alopecia is the most common type of hair loss in men. It is reported to have a strong effect on the quality of life, especially at a young age.
Arttu Järvinen, Jari Jokelainen, Laura Huilaja, Suvi-Päivikki Sinikumpu   +3 more
doaj   +1 more source

Pharmacotherapy of androgenetic alopecia – a literature review

Journal of Education, Health and Sport, 2022
INTRODUCTION: Androgenetic alopecia, also known as male pattern baldness, is a common dermatological problem. It manifests as hair thinning and miniaturization of hair follicles. In recent years, knowledge of the risk factors and pathomechanisms of this
Marcin Tyszkiewicz, Kinga Pożarowska, Agata Rosińska, Maciej Orczykowski   +3 more
doaj   +1 more source

Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia [PDF]

, 2016
INTRODUCTION: Long-term adverse symptoms of men who used oral finasteride against androgenic alopecia have been recently described as post-finasteride syndrome (PFS).
Cauci, Sabina, Cecchin, Erika, Chiriac\uf2, Giovanni, Stinco, Giuseppe, Toffoli, Giuseppe, Trombetta, Carlo, Xodo, Serena   +6 more
core   +2 more sources

A alopecia androgenética na consulta de tricologia do Hospital Geral de Santo António (cidade do Porto, Portugal) entre 2004 e 2006: estudo descritivo com componente analítico Androgenetic alopecia in trichology consultation at the Hospital Geral de Santo António (Oporto - Portugal, 2004-2006): a descriptive study with an analytic component

Anais Brasileiros de Dermatologia, 2008
FUNDAMENTOS: A alopecia androgenética é a causa mais comum de perda progressiva de cabelo. Geralmente ocorre em doentes com predisposição hereditária para esse tipo de alopecia e com androgénios circulantes.
Inês Lobo, Susana Machado, Manuela Selores   +2 more
doaj   +1 more source

Deep Learning-based Trichoscopic Image Analysis and Quantitative Model for Predicting Basic and Specific Classification in Male Androgenetic Alopecia

Acta Dermato-Venereologica, 2022
Since the results of basic and specific classification in male androgenetic alopecia are subjective, and trichoscopic data, such as hair density and diameter distribution, are potential quantitative indicators, the aim of this study was to develop a deep
Meng Gao, Yue Wang, Haipeng Xu, Congcong Xu, Xianhong Yang, Jin Nie, Ziye Zhang, Zhixuan Li, Wei Hou, Yiqun Jiang   +9 more
doaj   +1 more source

The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms

JEADV Clinical Practice, 2022
Androgenetic alopecia is one of the most common dermatologic disorders in the daily clinical practice of dermatologists. Despite it is such a common entity, few medications are FDA‐approved for its treatment.
Miguel Dominguez‐Santas, Borja Diaz‐Guimaraens, David Saceda‐Corralo, Angela Hermosa‐Gelbard, Oscar Muñoz‐Moreno Arrones, Cristina Pindado‐Ortega, Diego Fernandez‐Nieto, Juan Jimenez‐Cauhe, Daniel Ortega‐Quijano, Ana Suarez‐Valle, Pedro Jaen‐Olasolo, Sergio Vaño‐Galvan   +11 more
doaj   +1 more source